Sun Jie, Xiong Ju, Zhen Yan, Chen Zhao-Lun, Zhang Hua
Department of ENT, the First Affiliated Hospital of Xinjiang Medical University, China.
Asian Pac J Cancer Prev. 2012;13(11):5439-44. doi: 10.7314/apjcp.2012.13.11.5439.
To explore the correlation of human papillomavious (HPV) infection with expression of p53 and proliferating cell nuclear antigen (PCNA) in patients with different ethnicity in Xinjiang, China.
166 biopsy specimens from 83 laryngeal squamous cell carcinomas (LSCC), 63 laryngeal papillomas (LP), and 20 laryngeal inflammatory polyps (LIP) were included in this study. HPV infection was determined by polymerase chain reaction (PCR) using specific types of HPV primers. Expression of p53 and PCNA was assessed using immunohistostaining.
The frequency of HPV 6/11 was higher in LP (33.3%) than in LSCC (9.6%) (P<0.0005), whereas the frequency of HPV 16/18 was higher in LSCC (37.3%) than in LP (6.3%) (P<0.0005). Patients of the Han ethnic group with LSCC had a higher infection rate with HPV 6/11 or HPV 6/11 and HPV 16/18 coinfection than those of Uygur and Kazak ethnicity (P<0.05). Overexpression of p53 and PCNA were higher in LSCC (62.7%, 57.8%) than in LP (38%, 33.3%) (P<0.005, and P<0.005, respectively). That of p53 was not associated with lymph-node metastases and clinical stages, but overexpression of PCNA closely correlated with clinical stage.
These results strongly implicate HPV6/11 infection in the carcinogenesis of LSCC and LP, respectively. There was a higher coincidence of increased malignancy of laryngeal tumors with overexpression of p53 and PCNA. Overexpression of p53 may serve as an early risk marker for malignant transformation in HPV infected cells while the overexpression of PCNA may serve as a late marker for progression of LSCC.
探讨中国新疆不同民族患者人乳头瘤病毒(HPV)感染与p53及增殖细胞核抗原(PCNA)表达的相关性。
本研究纳入了来自83例喉鳞状细胞癌(LSCC)、63例喉乳头状瘤(LP)和20例喉炎性息肉(LIP)的166份活检标本。采用特定类型的HPV引物通过聚合酶链反应(PCR)检测HPV感染情况。采用免疫组织化学染色评估p53和PCNA的表达。
LP中HPV 6/11的感染率(33.3%)高于LSCC(9.6%)(P<0.0005),而LSCC中HPV 16/18的感染率(37.3%)高于LP(6.3%)(P<0.0005)。汉族LSCC患者HPV 6/11或HPV 6/11与HPV 16/18合并感染的发生率高于维吾尔族和哈萨克族患者(P<0.05)。LSCC中p53和PCNA的过表达率(分别为62.7%、57.8%)高于LP(分别为38%、33.3%)(P<0.005,P<0.005)。p53的过表达与淋巴结转移及临床分期无关,但PCNA的过表达与临床分期密切相关。
这些结果有力地表明HPV6/11感染分别与LSCC和LP的致癌作用有关。喉肿瘤恶性程度增加与p53和PCNA过表达的一致性较高。p53的过表达可能作为HPV感染细胞恶性转化的早期风险标志物,而PCNA的过表达可能作为LSCC进展的晚期标志物。